Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22751641 | 0.94 | — | — | |
| SCHEMBL21453524 | 0.92 | KDM4E (0.36) | ALDH1A1KDM4EATML3MBTL1 | |
| SCHEMBL20689946 | 0.91 | KDM4E (0.35) | ALDH1A1KDM4EATML3MBTL1 | |
| SCHEMBL20689809 | 0.85 | — | — | |
| SCHEMBL22751657 | 0.84 | KDM4E (0.32) | ALDH1A1KDM4E | |
| SCHEMBL13964149 | 0.83 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL21453527 | 0.82 | KDM4E (0.33) | ALDH1A1KDM4EATML3MBTL1 | |
| SCHEMBL20689826 | 0.82 | KDM4E (0.30) | ALDH1A1KDM4E | |
| SCHEMBL22751639 | 0.82 | PDK2 (0.34) | — | |
| SCHEMBL22751627 | 0.81 | KDM4E (0.32) | ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190036034-A1 | COMPOUND FOR THERMALLY ACTIVATED DELAYED FLUORESCENCE AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | TRPA1, SLCO2A1, TMEM109 | ALDH1A1 81/4885CES2 760/4885BCHE 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.